Outset Medical has entered a multi-year agreement with US Renal Care to provide patients and caregivers access to home dialysis with the Tablo haemodialysis system.

The collaboration aims to meet the increasing demand for home dialysis solutions by expanding the availability of the Tablo system.

Designed for ease of use in the home setting, Tablo will be made available in 33 states where US Renal Care provides care.

Outset Medical said the patients dialysing using Tablo report that the system is easy to learn and operate in their home.

Outset Medical chair and CEO Leslie Trigg said: “Our collaboration with US Renal Care is an important step forward in providing dialysis patients with options for where, when and how they want to dialyse.

“Tablo was specifically designed to reduce the complexity of dialysis and help restore the identity and agency of patients who must dialyse to survive. We are pleased to partner with US Renal Care to advance this mission.”

Tablo's technology represents a considerable leap forward in dialysis treatment, offering a more streamlined and patient-friendly approach.

The system is designed for use in various settings, from hospitals to homes, and requires only a tap water connection and a standard electrical outlet.

US Renal Care co-chief operating officer Steve Nottingham said: “We strive to provide patients with new and innovative solutions that deliver the best outcomes possible.

“We have seen success using the Tablo system in our home hemodialysis program, and with our multi-year agreement with Outset, can continue providing our patients and caregivers access to lifesaving dialysis treatment in an easy-to-operate system, all in the comfort of their own homes.”

Tablo functions as a mobile dialysis clinic due to the integration of water purification and on-demand dialysate manufacturing. It also features a data analytics platform and allows for two-way wireless data transmission for a holistic approach to dialysis care.